PerkinElmer Biomedical Announces Board Approval to Change Stock Transfer Agent
NQ Score
0/100
N1 Content Completeness
3
AI Summary (NQ-processed)
PerkinElmer Biomedical Co., Ltd. announced that its board of directors has approved the change of its stock transfer agent from KGI Securities to Taishin Securities, effective October 1, 2026. Shareholders will conduct stock-related procedures with the new agent.